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Summary Gas exchange during exercise in patients with cystic fibrosis (CF) is
characterised by an elevated physiological deadspace to tidal volume ratio. While
this has been attributed to alveolar ventilation–perfusion mismatch, there are other
potential causes of the high proportion of wasted ventilation, including factors
relating to the volume and the ventilation of the airway deadspace. CF (n¼ 6, F¼ 1,
FEV1 26–63% pred) and control (n¼ 6, F¼ 2) subjects completed steady-state
exercise on a cycle ergometer. Gas exchange was measured breath-by-breath and
the volume of the airway deadspace (VDaw ) determined using the equal areas
method. Exercise data were interpolated to a CO2 output of 0.7 l/min. VDaw was
similar in the two groups both at rest and during exercise. However, the airway
deadspace ventilation ( ’VDaw ) (median (inter-quartile range)), patients, 6.8 (5.1–
7.1) l/min; controls, 4.9 (3.5–5.6) l/min, Po0.05) was significantly greater in the CF
group due to a greater respiratory frequency. These results indicate that in CF
patients, abnormally increased ’VDaw is an important contributor to the total
(physiological) deadspace ventilation. Exercise performance in CF might be
enhanced by efforts directed at facilitating an increase in exercise tidal volume
and therefore the adoption of a more efficient pattern of breathing.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
There is an increasing body of evidence regarding
the benefits of regular exercise to patients with
cystic fibrosis (CF).1,2 Higher initial levels of
aerobic fitness have also been shown to be
associated with an enhanced rate of survival.3
Furthermore, regular aerobic exercise can halt the
progressive decline in lung function that is a
feature of CF.4 These findings therefore give
impetus to efforts directed at finding ways to
enhance both the intensity and the duration of
aerobic exercise that patients with CF can under-
take on a regular basis.
During exercise in patients with CF, a large
proportion of their ventilation is wasted, as
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to tidal volume ratio ðVDphys=VTÞ; even in cases of
relatively mild lung disease.5 Elevated ventilatory
equivalents for oxygen ð ’VE= ’VO2Þ and carbon dioxide
ð ’VE= ’VCO2Þ are also seen and have been attributed to
alveolar ventilation–perfusion ð ’VA= ’OÞ mismatch.
6
While there is some evidence of altered ’VA/ ’Q
distributions in CF patients during exercise,7 the
causes of the characteristic elevation of VDphys=VT in
CF have not been fully investigated.
VDphys can be partitioned into alveolar ðVDalv Þ and
airway deadspaces (VDaw).
8 In functional terms ’VDaw
is related to the position of the interface between
airway and alveolar gas, where gas moves by
convection in the former and diffusion in the latter.
Given that there are estimated to be in excess of
100,000 interfaces distributed throughout the
bronchial tree,9 VDaw represents the volume of gas
exhaled before the mean of this distribution arrives
at the mouth. The size of VDaw is determined by the
interaction of a number of factors including airway
cross-sectional area and geometry, inspiratory and
early expiratory flow patterns and diffusion coeffi-
cient of the gas.8 A good example of this interac-
tion is a post-inspiratory pause, which favours a
proximal (mouthward) advancement of the inter-
face due to an increase in the time available for
diffusion. Conversely, an increase in respiratory
rate, by way of both reducing the time available for
diffusion and increased flow rates, would be
expected to shift the interface more distally,
thereby increasing the size of VDaw :
There are a number of features of CF-related
lung disease that could therefore potentially
impact on the size of VDaw : Bronchiectasis is a
significant feature in the progression of CF-related
lung disease10,11 and might be expected to increase
the volume of the conducting airways and therefore
be manifest as an increase in VDaw : In addition,
dynamic hyperinflation is a feature of the ventila-
tory response during exercise.12,13 The resultant
increase in the calibre of the airways could also
potentially contribute to an increase in VDaw :
Furthermore, in normal subjects, increases in
ventilation ( ’VE) during exercise are brought about
by increasing both tidal volume (VT) and respiratory
frequency (fR). In contrast, if the ability to increase
VT is limited and as a consequence, increases in ’VE
are brought about primarily by increasing fR, then
the increased flow rates may also increase the size
of VDaw :
There are no previous studies that measure VDaw
during exercise in patients with CF and compare
these directly to normal, healthy subjects. It is
therefore of value to determine if VDaw is abnor-
mally elevated and/or how much of a problem is a
high fR, low VT breathing pattern during exercise in
patients with CF. This study was therefore under-
taken to compare the size of VDaw in CF patients
during steady-state exercise with those of control
subjects, at a similar CO2 output ( ’VCO2).
Methods
Subjects
Six patients with CF, diagnosed on the basis of
clinical history and abnormal sweat electrolyte
measurements (chloride460mmol/l), were re-
cruited from the National Referral Centre for Adult
Cystic Fibrosis at St. Vincent’s University Hospital.
All patients were free of acute pulmonary exacer-
bation for at least 2 months. Six control subjects
were recruited from amongst university students.
The study was approved by the Ethics Committee of
St. Vincent’s University Hospital. All subjects gave
written informed consent.
Measurements
Anthropometric measurements were undertaken
and spirometry performed using the spirometry
module of the Vmax229 (Sensor Medics, Yorba
Linda, California, USA) and results expressed as a
percentage of the predicted values.14 Previous
experience indicated that CF patients with more
severe lung disease could perform at most 40W
before the onset of an exercise-induced metabolic
acidosis. The exercise protocol comprised of four
stages and was designed so that data would be
available over a comparable range of submaximal
steady-state ventilations. The first stage was at
rest and the second at 10W. The third stage was at
40W and the final stage selected with regard to the
subject’s ventilatory response at 40W (maximum
100 and 80W for control and CF subjects, respec-
tively) unless a subject’s ventilatory response at
10W indicated that they were unlikely to be able to
sustain a work rate greater than 40W. In this case
for their third and fourth stages comprised 20 and
40W, respectively. All subjects were instructed to
pedal at a rate of 50 rev/min. Across all subjects,
the respiratory quotient did not exceed unity,
except at the final work rate in a single CF patient,
where it rose to 1.03.
Bipolar electrocardiogram (SensorMedics, Yorba
Linda, CA, USA) and ear lobe pulse oximetry (Sat-
Trak, SensorMedics, Yorba Linda, CA, USA) were
monitored and recorded throughout the test.
Subjects wore a nose clip and a mouthpiece
connected to a hot-wire anemometer (Sensor
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Medics, Yorba Linda, CA, USA) for measurement of
flow which was digitally integrated to obtain tidal
volume. Oxygen and carbon dioxide were measured
continuously using fast response paramagnetic O2
and non-dispersive infrared CO2 analysers (Vmax
229, Sensor Medics, Yorba Linda, CA, USA). Calibra-
tion was carried out before each test using a
calibration syringe and precision oxygen and carbon
dioxide mixtures (SensorMedics, Yorba Linda, CA,
USA). The flow and gas concentration signals were
time aligned in order to compensate for the delay
due to the transit and response times of the
analysers. This was achieved by rapidly switching
between calibration gases using a solenoid valve
and timing the transit and response times of each
analyser. Data for each breath were stored on hard
disk for later analysis.
At the end of each stage, two sets of tidal loops
were captured and placed within the resting forced
flow-volume loop by instructing subjects to inspire
maximally to total lung capacity. Since two sets of
tidal loops were captured at each stage, the
inspiratory and expiratory reserve volumes (IRV
and ERV, respectively), were taken as the mean of
the two values.
Data analysis
Determination of VDaw requires the time-aligned
expiratory flow and CO2 fractional concentration
signals. From the analogue output module of the
Vmax229, the time-aligned signals of flow, O2 and
CO2 fractional concentrations were captured using
a data acquisition unit (MP100 workstation, Biopac
Systems, Santa Barbara, CA, USA) connected to an
Apple Macintosh computer. Since the digital to
analogue conversion rate of the Vmax229 was
125 Hz, the signals were sampled at 250Hz per
channel. Software control was provided by Acq-
Knowledge 3.2 (Biopac Systems, Santa Barbara, CA,
USA) with data stored to hard disk for subsequent
off-line analysis. Ten breaths were selected for
computation of VDaw from data at the end of each
stage. The breaths were selected consecutively
unless an unusually short or prolonged breath
occurred, in which case it was ignored and the
next breath selected.
VDaw was estimated using an algorithm
15 based on
Fowler’s equal areas method.16 The raw data points
were imported into a spreadsheet program (Excel
97, Microsoft, Redmond, WA, USA) and the data
reduced by taking the mean of groups of four
consecutive data points, giving a resolution of
62.5 Hz. The first 80ml of the data were discarded
as this represents the external deadspace between
the end of the mouthpiece and the gas sampling
port.
Data from the control and CF groups were
linearly interpolated in order to compare the
ventilatory and gas exchange responses at the
same CO2 load ð ’VCO2 ¼ 0:7 l=minÞ; which was close
to 40W.
Statistical analysis
All data are presented as median and inter-quartile
range. Data from the two groups were compared
using the non-parametric Mann–Whitney U test on
SPSS (ver. 10.0 for Windows, SPSS Inc., Chicago, IL,
USA). A P value of o0.05 was accepted as being
statistically significant.
Results
The age and height of the control subjects and the
CF patients were similar (Table 1). The body weight
tended to be lower in the CF group and the
difference approached statistical significance. All
spirometric indices were significantly reduced in
the CF group (Table 2). There were no significant
post-exercise falls in FEV1 in any of the subjects. At
rest, the median (inter-quartile range) VDaw (pa-
tients, 0.14(0.10–0.20) I; controls, 0.15(0.11–0.18)
I) was similar in the two groups (P¼ 0.749).
Figure 1 shows a plot of the individual VDaw versus
VT data and indicates that the former increased
with increases in VT in a similar manner in the two
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Table 1 Anthropometric data for control and CF groups.
Median (inter-quartile range) P-value
CF Control
(n¼ 6, F¼ 1) (n¼ 6, F¼ 2)
Age (years) 29 (19–34) 22 (19–29) 0.257
Height (m) 1.70 (1.63–1.79) 1.79 (1.66–1.84) 0.229
Weight (kg) 57 (47–68) 72 (58–74) 0.055
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groups. At the same CO2 output ð ’VCO2 ¼ 0:7 l=minÞ;
the size of VTwas similar in the two groups (Fig. 2),
but fR and hence ’VE were increased in the CF group.
The volume of the airway deadspace (VDaw) was also
similar in the two groups, but because of the
increased fR in the CF group, the airway deadspace
ventilation (VDaw) was significantly higher in the
patient group (Fig. 2).
Analysis of the captured tidal loops placed within
the resting forced expiratory flow-volume loops,
indicated that at rest, ERV was significantly
reduced in the CF group (Table 3). During exercise,
ERV was increased in the CF group, suggesting that
dynamic hyperinflation had occurred. This change
was significantly different from the reduction in
ERV observed in the control group. Furthermore,
the reduction in IRV in the CF group was signifi-
cantly greater than that observed in the controls.
Examination of the individual tidal loops from the
CF patients, indicated that at 40W, the expiratory
phase either met (n¼ 1) or exceeded (n¼ 5) the
resting forced expiratory flow loop (Fig. 3). There
was no evidence of flow limitation in the control
subjects (data not shown).
Discussion
At rest, there was no evidence of an increased
airway deadspace volume (VDaw) in the CF group.
Surprisingly, during exercise at the same CO2
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Table 2 Spirometric indices for control and CF groups.
Median (inter-quartile range) P-value
CF Control
FVC (%pred) 62 (52–93) 113 (94–124) o0.05
FEV1 (%pred) 47 (25–59) 107 (96–120) o0.01
FEV1/FVC (%) 57 (41–67) 88 (77–95) o0.01
FEF25–75% (%pred) 19 (7–27) 90 (77–123) o0.01
PEF (%pred) 63 (43–85) 99(92–115) o0.01
Abbreviations: FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; FEF25–75%: mean expiratory flow over 25–75%
FVC; PEF: peak expiratory flow; %pred: percentage of predicted value.
Figure 1 Plot of individual airway deadspace volume (VDaw ) data both at rest and during exercise versus tidal volume
(VT). Open circles joined with solid lines indicate individual control subjects; filled circles joined with dashed lines
indicate individual CF subjects.
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Figure 2 Comparison of ventilatory changes with exercise in control and CF groups. Open circles indicate individual
control subjects; filled circles indicate individual CF subjects; solid horizontal bars indicate group mean data at rest (R)
and during exercise (E) at a ’VCO2 of 0.7 l/min. Abbreviations: VT: tidal volume; VDaw : volume of airway deadspace; fR:
respiratory frequency; ’VE: minute ventilation; ’VDaw : ventilation of airway deadspace; ’VA: alveolar ventilation.
Table 3 Changes in tidal volume and inspiratory and expiratory reserve volumes between rest and 40W.
Rest Median (inter-quartile range) P-value Change Median (inter quartile range) P-value
CF Control CF Control
VT (I) 0.64 0.70 0.361 þ 0.39 þ 0.34 0.361
(0.49–0.94) (0.64–0.91) (þ 0.26–þ 0.45) (0.02–þ 0.47)
IRV (I) 1.44 2.04 0.068 0.51 0.03 o0.05
(1.00–1.99) (1.75–3.04) (0.78–0.28) (0.29–þ 0.10)
ERV(I) 0.73 2.05 o0.05 þ 0.10 0.18 o0.05
(0.47–1.37) (1.56–2.16) (0.04–þ 0.39) (0.27–0.03)
Abbreviations: VT: tidal volume; IRV: inspiratory reserve volume; ERV: expiratory reserve volume.
Note: In error, resting tidal loops for a single control subject were not stored for analysis. Thus in this table the data for the
control group are for only n¼ 5, F¼ 2.
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output, despite some evidence of dynamic hyper-
inflation in the CF group, the volume of this
deadspace in the patient group was not elevated
above that of the control group. However, the
higher fR in the CF group at the same CO2 output
resulted in a disproportionate increase in airway
deadspace ventilation ( ’VDaw) compared to the
control group.
Given the various factors that can affect the
location of the interface between airway and
alveolar gas, it should not be surprising that the
size of VDaw increased with exercise (Fig. 1). Indeed,
even if only anatomical factors were considered,
VDaw would be expected to increase with the degree
of lung inflation.17 However, during exercise,
superimposed on top of this factor are changes in
inspiratory and expiratory flow patterns and rates.
At this point it is also worth considering two as yet
unmentioned aspects of ventilation, namely lami-
nar versus turbulent flow and the distribution of the
time constants of the gas exchange units in the
lungs. Increased inhomogeneity of time constants
will result in a greater spread in the distribution of
interfaces arriving at the mouth. Conversely,
turbulent gas flow will tend to speed up airway
washout, thereby reducing the spread of the
distribution of interfaces, and thus the size of
phase II.8 The effect of inhomogeneity of time
constants will become more marked at higher flow
rates. There is some evidence from elevated phase
III slopes during a single breath nitrogen washout
test in patients with CF that this may be a
problem.18,19 If there were a population of gas
exchange units with particularly long time con-
stants, then the interfaces from these units would
be subsumed with alveolar gas from the rest of the
lung. In this case, since there is insufficient
information contained in the CO2 concentration
versus flow trace measured at the mouth to
delineate these late arriving interfaces, the deter-
mined value of VDaw should be considered a
minimum estimate. It is therefore possible, that
in the present study there was a degree of
underestimation in the size of VDaw in the CF
patients.
While not previously reported during exercise,
Wood et al.20 determined VDaw at rest in pediatric
CF patients and found values similar to those in
healthy children. We have extended their finding,
by demonstrating that the size of VDaw is not
elevated in adult CF patients compared to control
subjects during exercise. It might have been
expected that VDaw would be elevated in the CF
patients, since bronchiectasis is a major feature of
the disease process.10,11 However, a potential
explanation for the lack of a demonstrable increase
in ’VDaw in the CF patients is the presence of airway
plugging, a feature observed in radiographs and
post-mortem studies.21,22 Such blockages would
result in functional loss of part of the bronchial
tree and as a consequence the measured volume of
gas in the conducting airways would not be
increased, despite the presence of bronchiectatic
lung disease.
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Figure 3 Panels (A)–(F) show individual tidal loops
captured 40W and placed inside resting forced flow-
volume loops for the six CF patients. (F) indicates
resting forced flow-volume loop; (....) indicates resting
tidal breathing; (- - - ) indicates tidal loop captured at
40W. Note difference in scale in panel F.
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Dynamic hyperinflation is apparent during ex-
ercise in patients with CF,12,13 an adaptation also
observed in the present study (Table 3). In normal
subjects at rest, the size of VDaw has been shown to
increase with increasing end-inspiratory lung vo-
lume.23–25 In the absence of measurements of
residual volume and total lung capacity it is not
possible to make direct comparisons between the
two groups. However, the size of the reduction in
IRV in the CF group shown in Table 3 in going from
rest to 40W indicates a relative increase in lung
volume of approximately 440ml compared to the
control group. Results from the above studies
indicate that while varying end-inspiratory lung
volume at rest in normal subjects, the size of
VDaw increased at the rate of about 3ml per 100ml
increase in lung volume. On this basis, going from
rest to 40W, dynamic hyperinflation would have
contributed an increase in the region of 13ml to
the size of VDaw : Therefore, much larger degrees of
dynamic hyperinflation than seen in the present
study would be required before this would become
a physiologically significant effect.
The increased fR and therefore flow rates seen in
the CF patients at the same ’VCO2 as the control
subjects did not appear to result in an increase in
the size of VDaw : However, the increased flow in the
CF group may have resulted in a degree of under-
estimation in the size of VDaw due to an exacerbation
of the effect of inhomogeneity of time constants
between gas exchange units, as discussed above.
In contrast to the above, we observed an
abnormal increase in the ventilation of the airway
deadspace ( ’VDaw) in the CF group, arising as a
consequence of the breathing strategy adopted by
the CF patients. While the disproportionate in-
crease in fR did not impair gas exchange by
increasing the size of VDaw ; the lack of a compensa-
tory increase in VT resulted in a reduction in
ventilatory efficiency, resulting in a higher propor-
tion of wasted ventilation. The clinical implications
of this finding for patients with CF are important.
Breathing at higher lung volumes is a recognised
adaptation to prevent dynamic airway collapse and
therefore minimise flow limitation in obstructive
lung diseases.26 However, it means operating on a
less compliant region of the pressure–volume curve
of the lungs and so in order to prevent diaphrag-
matic fatigue, the size of any increase in VT is
constrained.27 At a ’VCO2of 0.7 l/min,
’VDaw was on
average 36% greater in the CF group than in the
control group. At higher intensities of exercise,
ever greater dependence on fR rather than VT to
bring about the necessary increase in ventilation,
will result in this difference becoming even more
significant.
Several studies of different inspiratory muscle
training protocols (i.e. various combinations of
loading and duration) have been undertaken in
patients with CF.28–30 The study by Sawyer et al.
had the longest training period (10 weeks) and was
the only one to demonstrate an increase in maximal
exercise capacity. However, since no gas exchange
measurements were made, it is not possible to
comment on the reason(s) for the increase.
Furthermore, none of these studies had the primary
aim of bringing about increases in exercise VT.
Increases in VT in normal, healthy subjects have
been produced by means of servo-assisted positive
pressure ventilation.31,32 The results of the present
study indicate that were it possible to facilitate
such an increase in VT in patients with CF, it would
be likely to be of significant benefit to their
exercise performance. However, use of servo-
assisted positive pressure ventilation in patients
with CF will necessitate the development of a
protocol that permits the application of a training
stimulus sufficient to bring about increases in VT
while at the same time avoiding exhausting the
diaphragm.
In conclusion, the major findings of this study
were that, in contrast to our initial expectations,
the airway deadspace volume is not elevated during
exercise in patients with CF. However, because in
these patients the size of the increase in VT was
limited, the increased ’VE required to maintain gas
exchange was therefore brought about primarily by
increasing fR. As a result their airway deadspace
ventilation was significantly elevated and contri-
butes significantly to the high proportion of wasted
ventilation observed in these patients.
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